ScoreWhy is Spero Therapeutics, Inc. ?
1
The company has declared positive results for the last 2 consecutive quarters
- OPERATING CASH FLOW(Y) Highest at USD 7.24 MM
- NET SALES(HY) Higher at USD 39.92 MM
- NET PROFIT(HY) Higher at USD 24.32 MM
2
With ROE of 15.96%, it has a very attractive valuation with a 2.29 Price to Book Value
- Over the past year, while the stock has generated a return of -22.45%, its profits have risen by 113.9% ; the PEG ratio of the company is 0.1
3
High Institutional Holdings at 47.06%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
- Their stake has increased by 1.86% over the previous quarter.
Real-Time Research ReportHow much should you buy?
- Overall Portfolio exposure to Spero Therapeutics, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Spero Therapeutics, Inc. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Spero Therapeutics, Inc.
-26.82%
1.01
59.01%
S&P 500
25.41%
1.92
13.25%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
51.70%
EBIT Growth (5y)
14.87%
EBIT to Interest (avg)
-40.38
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.39
Sales to Capital Employed (avg)
1.02
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
47.06%
ROCE (avg)
20.70%
ROE (avg)
5.97%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
14
Industry P/E
Price to Book Value
2.29
EV to EBIT
-96.58
EV to EBITDA
-96.58
EV to Capital Employed
4.66
EV to Sales
1.62
PEG Ratio
0.13
Dividend Yield
NA
ROCE (Latest)
-0.12%
ROE (Latest)
15.96%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
Bearish
Bollinger Bands
Mildly Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
No Trend
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend25What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD 7.24 MM
NET SALES(HY)
Higher at USD 39.92 MM
NET PROFIT(HY)
Higher at USD 24.32 MM
ROCE(HY)
Highest at 35.12%
RAW MATERIAL COST(Y)
Fallen by 0% (YoY
DEBTORS TURNOVER RATIO(HY)
Highest at 4.5 times
-1What is not working for the Company
CASH AND EQV(HY)
Lowest at USD 96.39 MM
Here's what is working for Spero Therapeutics, Inc.
Net Sales
At USD 39.92 MM has Grown at 175.91%
Year on Year (YoY)MOJO Watch
Sales trend is very positive
Net Sales (USD MM)
Net Profit
At USD 24.32 MM has Grown at 172.15%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very positive
Net Profit (USD MM)
Net Sales
Higher at USD 39.92 MM
than preceding 12 month period ended Mar 2026MOJO Watch
In the half year the company has already crossed sales of the previous twelve months
Net Sales (USD MM)
Net Profit
Higher at USD 24.32 MM
than preceding 12 month period ended Mar 2026MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (USD MM)
Operating Cash Flow
Highest at USD 7.24 MM
in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Debtors Turnover Ratio
Highest at 4.5 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Raw Material Cost
Fallen by 0% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Spero Therapeutics, Inc.
Cash and Eqv
Lowest at USD 96.39 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
